Related Experiment Videos
Poor prognoses following left hepatic trisegmentectomies for cancer
H Hasegawa1, S Yamasaki, M Makuuchi
1Department of Surgical Oncology, National Cancer Center Hospital, Tokyo.
Japanese Journal of Clinical Oncology
|September 1, 1989
Summary
Left hepatic trisegmentectomy for liver tumors showed high complication rates and poor survival. The procedure resulted in significant mortality and morbidity, with tumor recurrence common in survivors.
Area of Science:
- Hepatobiliary surgery
- Surgical oncology
- Gastroenterology
Background:
- Hepatocellular carcinoma and gallbladder cancer with liver metastases are serious conditions.
- Surgical resection is a primary treatment modality for these liver tumors.
- Left hepatic trisegmentectomy is a complex surgical procedure for extensive liver tumors.
Purpose of the Study:
- To evaluate the safety and efficacy of left hepatic trisegmentectomy.
- To assess outcomes for patients with hepatocellular carcinoma and liver metastases undergoing this procedure.
Main Methods:
- Retrospective analysis of six patients undergoing left hepatic trisegmentectomy.
- Included patients with hepatocellular carcinoma and gallbladder cancer with liver metastases.
- Four patients also underwent resection of the left caudate lobe.
Main Results:
- Two hospital deaths occurred due to bleeding peptic ulcer and anaphylactic shock.
- One patient experienced prolonged bile leakage, which resolved spontaneously.
- All surviving patients developed tumor recurrence within 3.5 to 11 months post-surgery.
Conclusions:
- Left hepatic trisegmentectomy is associated with significant perioperative complications and mortality.
- The procedure offers limited long-term survival benefits for these liver tumors.
- Indications for left trisegmentectomy in treating these specific liver malignancies appear limited.